Q3 2024 Earnings Forecast for U.S. Physical Therapy, Inc. (NYSE:USPH) Issued By William Blair

U.S. Physical Therapy, Inc. (NYSE:USPH) – Investment analysts at William Blair lowered their Q3 2024 earnings per share estimates for shares of U.S. Physical Therapy in a research report issued to clients and investors on Tuesday, August 13th. William Blair analyst J. Haase now forecasts that the company will post earnings per share of $0.73 for the quarter, down from their prior forecast of $0.83. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.85 per share. William Blair also issued estimates for U.S. Physical Therapy’s Q4 2024 earnings at $0.77 EPS, FY2024 earnings at $2.74 EPS, Q2 2025 earnings at $0.83 EPS, Q3 2025 earnings at $0.90 EPS, Q4 2025 earnings at $0.84 EPS and FY2025 earnings at $3.17 EPS.

A number of other equities research analysts also recently commented on the stock. Barrington Research reduced their price objective on shares of U.S. Physical Therapy from $122.00 to $108.00 and set an “outperform” rating for the company in a research report on Thursday. StockNews.com cut U.S. Physical Therapy from a “hold” rating to a “sell” rating in a report on Tuesday, August 13th. One analyst has rated the stock with a sell rating and three have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $112.50.

U.S. Physical Therapy Price Performance

Shares of NYSE USPH opened at $84.21 on Friday. The stock has a fifty day moving average price of $93.37 and a 200 day moving average price of $99.57. U.S. Physical Therapy has a 1-year low of $78.08 and a 1-year high of $113.63. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.88 and a quick ratio of 2.16. The company has a market cap of $1.27 billion, a PE ratio of 68.46, a P/E/G ratio of 3.17 and a beta of 1.38.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Tuesday, August 13th. The company reported $0.73 EPS for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The business had revenue of $167.19 million during the quarter, compared to analysts’ expectations of $163.34 million. During the same period in the previous year, the company posted $0.76 earnings per share. U.S. Physical Therapy’s quarterly revenue was up 10.4% on a year-over-year basis.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Silvercrest Asset Management Group LLC acquired a new stake in U.S. Physical Therapy during the 1st quarter valued at $8,158,000. Harbor Capital Advisors Inc. increased its position in U.S. Physical Therapy by 292.5% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 7,584 shares of the company’s stock worth $701,000 after purchasing an additional 5,652 shares in the last quarter. Southernsun Asset Management LLC increased its position in U.S. Physical Therapy by 5.9% during the 4th quarter. Southernsun Asset Management LLC now owns 479,214 shares of the company’s stock worth $44,634,000 after purchasing an additional 26,758 shares in the last quarter. Norden Group LLC raised its stake in U.S. Physical Therapy by 1,841.6% in the 1st quarter. Norden Group LLC now owns 63,938 shares of the company’s stock valued at $7,217,000 after purchasing an additional 60,645 shares during the last quarter. Finally, Semanteon Capital Management LP purchased a new position in U.S. Physical Therapy in the 4th quarter valued at about $767,000.

Insiders Place Their Bets

In related news, CEO Christopher J. Reading sold 2,900 shares of the firm’s stock in a transaction that occurred on Thursday, May 30th. The stock was sold at an average price of $100.26, for a total value of $290,754.00. Following the completion of the transaction, the chief executive officer now directly owns 95,838 shares of the company’s stock, valued at approximately $9,608,717.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CEO Christopher J. Reading sold 2,900 shares of the business’s stock in a transaction dated Thursday, May 30th. The shares were sold at an average price of $100.26, for a total value of $290,754.00. Following the sale, the chief executive officer now directly owns 95,838 shares in the company, valued at approximately $9,608,717.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Christopher J. Reading sold 1,100 shares of the stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $102.13, for a total transaction of $112,343.00. Following the completion of the sale, the chief executive officer now directly owns 99,738 shares in the company, valued at $10,186,241.94. The disclosure for this sale can be found here. 1.70% of the stock is currently owned by company insiders.

U.S. Physical Therapy Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, September 13th. Shareholders of record on Friday, August 23rd will be given a dividend of $0.44 per share. The ex-dividend date of this dividend is Friday, August 23rd. This represents a $1.76 annualized dividend and a yield of 2.09%. U.S. Physical Therapy’s payout ratio is currently 143.09%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.